Alzheimer's disease & dementia

World experts target guidance on managing dementia symptoms

New research which brings together the views of the world's leading experts has concluded that non-drug approaches should be prioritised in treating agitation in people with Alzheimer's disease.

Medications

Lurasidone in schizophrenia: Added benefit is not proven

The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment ...

Neuroscience

Promising new treatments for multiple sclerosis

(Medical Xpress)—New treatments for multiple sclerosis (MS) using common anti-psychotic agents have been discovered by Victoria University of Wellington researchers.

Psychology & Psychiatry

Stimulant, antipsychotic combo improves aggressive behavior

(HealthDay)—For children with attention deficit/hyperactivity disorder (ADHD) and aggressive disorders, the addition of risperidone to a combination of parent training and psychostimulant is associated with moderate improvement ...

Psychology & Psychiatry

'Exposure therapy' along with antidepressants may help with OCD

(HealthDay)—New research suggests that patients with obsessive-compulsive disorder do better when they combine intensive "exposure therapy" with an antidepressant rather than taking a common two-drug combination.

page 1 from 2